153 related articles for article (PubMed ID: 11033750)
1. Compliance and psychological reactance in schizophrenia.
Moore A; Sellwood W; Stirling J
Br J Clin Psychol; 2000 Sep; 39(3):287-95. PubMed ID: 11033750
[TBL] [Abstract][Full Text] [Related]
2. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
3. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
Byerly MJ; Fisher R; Carmody T; Rush AJ
J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome.
Awad AG; Voruganti LN; Heslegrave RJ; Hogan TP
Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():55-9. PubMed ID: 8803661
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
Tsang HW; Fung KM; Corrigan PW
J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
[TBL] [Abstract][Full Text] [Related]
7. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
8. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
Rummel-Kluge C; Schuster T; Peters S; Kissling W
Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
[TBL] [Abstract][Full Text] [Related]
9. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
Löffler W; Kilian R; Toumi M; Angermeyer MC
Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
[TBL] [Abstract][Full Text] [Related]
11. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
12. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
13. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors.
Cabeza IG; Amador MS; López CA; González de Chávez M
Schizophr Res; 2000 Jan; 41(2):349-55. PubMed ID: 10708344
[TBL] [Abstract][Full Text] [Related]
14. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
Mayer C; Soyka M
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
16. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
18. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.
Garavan J; Browne S; Gervin M; Lane A; Larkin C; O'Callaghan E
Compr Psychiatry; 1998; 39(4):215-9. PubMed ID: 9675506
[TBL] [Abstract][Full Text] [Related]
19. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
[TBL] [Abstract][Full Text] [Related]
20. Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.
Kampman O; Lehtinen K; Lassila V; Leinonen E; Poutanen O; Koivisto A
Schizophr Res; 2000 Oct; 45(3):223-34. PubMed ID: 11042440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
